SIFAP1
Stroke in Young Fabry Patients (SIFAP1): Frequency of Fabry Disease in Young Stroke Patients
|
Status:
Ongoing. Study began with a pilote phase in April 2007 and started in January 2008. Expected completion of the study is December 31, 2009.
Purpose:
To determine the frequency of Fabry disease in an unselected group of young stroke patients.
Location(s):
Austria, Belgium, Croatia, Finland, France, Georgian Republic, Germany, Italy, Malta, Poland, Portugal, Republic of Ireland, Spain, United Kingdom.
Year Started:
2008
Year Finished:
2009
Design:
Screening, cross-sectional, defined population, prospective study.
Inclusion Criteria
Patients with acute ischemic stroke or transient ischemic attack; MRI-scan evidence of associated corresponding brain infarction or hemorrhage, regardless of the duration of symptoms (also patients with no signs of stroke in the MRI can be included if a stroke-experienced neurologist has done the initial diagnosis as ischemic stroke, transient ischemic attack or hemorrhage); detailed MRI documentation at admission to entry to the study; diagnostic procedures for CVE according to the EUSI recommendations.
Exclusion Criteria
Acute ischemic stroke or transient ischemic attack longer than 3 months before enrolment into the study; diagnosis of the CVE within the last 3 months has been done by a non-neurologist if there is no MRI-scan evidence of associated brain infarction or hemorrhage; no detailed MR documentation at admission to entry to the study.
Primary Outcome:
Frequency of Fabry disease.
Source of Information:
ClinicalTrials.gov
|
|
Web Links and Publications:
|
|
This information last updated on: 10/7/2009
Reviewed on: 10/07/2009.
|
Trials
Directories